[LG 0215] FEBRUARY 2015 Sub. code: 1502
B.Sc. CARDIAC TECHNOLOGY
FIRST YEAR
PAPER II – PHARMACOLOGY RELATED TO CARDIAC TECHNOLOGY
Q.P. Code : 801502
Time: Three Hours Maximum: 100 Marks
Dr. MGR University Previous Years Question Papers
Answer all questions
I. Elaborate on: (3 x 10 = 30)
1. Enumerate drugs used in angina. Write the mechanism of action, adverse effects and uses of nitrates.
2. Write briefly about anti platelet drugs.
3. Enumerate hypolipidemic drugs. Describe the actions , uses and adverse effects of statins.
II. Write Notes on: (8 x 5 = 40)
1. Enalapril.
2. Nifedipine.
3. Metoprolol.
4. Lidocaine.
5. Low molecular weight heparin.
6. Spironolactone.
7. Streptokinase.
8. Dopamine.
III. Write Notes on: (10 x 3 = 30)
1. Complications of high ceiling diuretics.
2. Uses of hydrocortisone.
3. Enumerate Cephalosporins.
4. Mention Proton Pump inhibitors. What are their uses?
5. Mention the various techniques in local anaesthesia.
6. Diphenhydramine.
7. Treatment of heparin toxicity.
8. Midazolam.
9. Niacin.
10. Adenosine.
B.Sc. CARDIAC TECHNOLOGY
FIRST YEAR
PAPER II – PHARMACOLOGY RELATED TO CARDIAC TECHNOLOGY
Q.P. Code : 801502
Time: Three Hours Maximum: 100 Marks
Dr. MGR University Previous Years Question Papers
Answer all questions
I. Elaborate on: (3 x 10 = 30)
1. Enumerate drugs used in angina. Write the mechanism of action, adverse effects and uses of nitrates.
2. Write briefly about anti platelet drugs.
3. Enumerate hypolipidemic drugs. Describe the actions , uses and adverse effects of statins.
II. Write Notes on: (8 x 5 = 40)
1. Enalapril.
2. Nifedipine.
3. Metoprolol.
4. Lidocaine.
5. Low molecular weight heparin.
6. Spironolactone.
7. Streptokinase.
8. Dopamine.
III. Write Notes on: (10 x 3 = 30)
1. Complications of high ceiling diuretics.
2. Uses of hydrocortisone.
3. Enumerate Cephalosporins.
4. Mention Proton Pump inhibitors. What are their uses?
5. Mention the various techniques in local anaesthesia.
6. Diphenhydramine.
7. Treatment of heparin toxicity.
8. Midazolam.
9. Niacin.
10. Adenosine.
0 comments:
Pen down your valuable important comments below